Trials / Terminated
TerminatedNCT02966184
Comparison of Albuterol for Status Asthmaticus
Comparison of Benzalkonium Chloride Containing Albuterol Versus Preservative Free Albuterol for the Treatment of Status Asthmaticus
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Norton Healthcare · Academic / Other
- Sex
- All
- Age
- 5 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to compare the length of continuous albuterol administration between two different albuterol formulations, BAC containing albuterol versus preservative free albuterol.
Detailed description
The primary objective of this study is to compare the length of continuous albuterol administration between patients receiving BAC containing albuterol versus preservative free albuterol. Secondary objectives include comparison of therapy escalation, asthma scores, forced expiratory volume in one second (FEV1) at discharge, length of hospital stay, and cost.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | preservative free albuterol | Preservative free albuterol for nebulization |
Timeline
- Start date
- 2018-09-10
- Primary completion
- 2018-10-25
- Completion
- 2018-10-25
- First posted
- 2016-11-17
- Last updated
- 2021-05-20
- Results posted
- 2021-05-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02966184. Inclusion in this directory is not an endorsement.